New partners – Forian and Syndesis Health join the Atropos Evidence Network and new customer Translational Drug Development (TD2) gains immediate access to clinical insights generated from Atropos Health’s new data contributors.
Read the full press release
Highlights:
-
The growing number of datasets and partners expands the number and type of use cases for the Atropos Evidence Network
-
The Atropos Evidence Network expansion signifies the company’s commitment to life science and healthcare organizations who are seeking evidence for decision-making in medicine.
-
With Real World Data Score™ (RWDS) & Real World Fitness Score™ (RWFS) users can select the dataset that is the most suitable to answer each question. Data contributors also receive transparent, analytically driven feedback on usage and their own data quality and strengths.
-
The Atropos Evidence Network operates on GENEVA OS™ (Generative Evidence Acceleration Operating System), a federated model, forming secure, cloud-based connections between healthcare data proprietors and clinical insight seekers across the healthcare ecosystem. De-identified data doesn’t change hands – reducing data security and identity management risks,
-
New customer TD2 will utilize Atropos Health to add automation, efficiency, and transparency to their own processes. The Green Button Informatics Consult Service, the Atropos Evidence Network and Alexandria™ (fka Atropos Evidence™ Library) allows their team to pose clinical questions to a variety of datasets. Within 48 hours, the user receives a novel retrospective observational study in response that can drive the scale of evidence generation needed to enable personalized evidence for everyone.
About Our Partnters
Forian provides a unique suite of data management capabilities and proprietary information and analytics solutions to optimize and measure operational, clinical and financial performance for customers within the traditional and emerging life sciences and healthcare payer and provider segments. Forian has industry leading expertise in acquiring, integrating, normalizing and commercializing large scale healthcare data assets. Forian’s information products overlay sophisticated data management and data science capabilities on top of a comprehensive clinical data lake to identify unique relationships, create distinctive information assets and generate proprietary insights. For more information, please visit the company’s website at www.forian.com.
Syndesis Health is the data and technology catalyst to a multi-continent network of healthcare and life sciences organizations. Its primary aim is to enhance global health outcomes and equity through its secure data platform, Syntium, and the Syndesis Health Network, a member community promoting research collaboration, information sharing, and access to common tools. For more information, please visit the company’s website at www.syndesis.com
TD2 is a leader in precision oncology, providing innovative services for improved drug development. Using a dedicated, expert team with broad experience and understanding in cancer medicine, TD2 is uniquely positioned to support accelerated development of novel therapeutics. Rigorous and high-throughput translational preclinical development services, combined with regulatory affairs expertise, enables customized clinical trial design and execution. Our unique Oncology Ecosystem encourages the timely selection of patient populations who are most likely to benefit from a new agent, and the rapid identification of clinically significant endpoints. TD2 is committed to reducing the risks and uncertainty inherent in the drug development process with the ultimate goal of accelerating patient access to promising treatments. For more information, visit www.TD2inc.com.